Fidelity D&D Bancorp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$285K Buy
310
+45
+17% +$45.6K 0.11% 78
2025
Q4
$285K Sell
265
-16
-6% -$15.3K 0.12% 75
2025
Q3
$214K Sell
281
-40
-12% -$29.8K 0.12% 96
2025
Q2
$250K Hold
321
0.15% 86
2025
Q1
$265K Hold
321
0.17% 82
2024
Q4
$248K Sell
321
-4
-1% -$3.31K 0.16% 93
2024
Q3
$288K Sell
325
-20
-6% -$18K 0.19% 77
2024
Q2
$312K Hold
345
0.24% 69
2024
Q1
$268K Sell
345
-50
-13% -$35.6K 0.2% 76
2023
Q4
$230K Buy
+395
New +$231K 0.18% 86
2023
Q1
$268K Buy
+345
New +$116K 0.2% 76

Other funds holding LLY

Fidelity D&D Bancorp's LLY Position: Q1 2026 in Review

Fidelity D&D Bancorp increased its Eli Lilly (LLY) stake by 17% in Q1 2026, buying an estimated $45.6K and bringing the position to 310 shares worth $285K. The position accounts for 0.11% of the portfolio, ranked #78.

Fidelity D&D Bancorp first reported a position in LLY in Q1 2023 and has held it in 11 quarters since. The position peaked at $312K in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fidelity D&D Bancorp held 310 shares of Eli Lilly worth $285K as of Q1 2026.
  • Fidelity D&D Bancorp bought 45 Eli Lilly shares in Q1 2026, an estimated $45.6K.
  • Eli Lilly made up 0.11% of Fidelity D&D Bancorp's portfolio in Q1 2026, its #78 holding.
  • Fidelity D&D Bancorp first reported a position in Eli Lilly in Q1 2023 and has held it in 11 quarters since.
  • Fidelity D&D Bancorp's Eli Lilly position peaked at $312K in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fidelity D&D Bancorp's 13F filing for Q1 2026, filed 30 Apr 2026.